If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -3.00 (-0.11%)
Bid:
2,618.00
Ask:
2,620.00
Spread: 2.00 (0.076%)
Market Cap: £23.27b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Annual Financial Report

6 Jun 2025 11:30

RNS Number : 8322L
Experian plc
06 June 2025
 

Experian plc

 

 

Annual Report and Accounts for the year ended 31 March 2025, Notice of Annual General Meeting 2025 and Proxy Form

 

 

6 June 2025 - Experian plc, the global data and technology company (the "Company"), hereby notifies the market, in accordance with UK Listing Rule 6.4.1(R), that the above documents are being submitted to the National Storage Mechanism and they will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Copies of the Annual Report and Accounts and the Notice of Annual General Meeting are also available on the Company's website at www.experianplc.com.

 

The 2025 Annual General Meeting of the Company will be held at The Merrion Hotel, Upper Merrion Street, Dublin 2, D02 KF79, Ireland on Wednesday 16 July 2025 at 9.30am. A summary of the resolutions and the reasons they are being proposed is set out in the explanatory notes which accompany the Notice of Annual General Meeting.

 

 

Contact:

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSBGGDLXDGDGUL
Date   Source Headline
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:40 pmRNSNotification of issuance of equity securities
27th Feb 20264:15 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20265:05 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20261:00 pmRNSDirector/PDMR Shareholding
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20262:49 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSCapital allocation update
27th Jan 20261:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading update, third quarter
16th Jan 20265:39 pmRNSFirst interim dividend
16th Jan 202611:41 amRNSBlock listing Return
8th Jan 20267:00 amRNSExperian plc Chair Announcement
31st Dec 202511:23 amRNSTotal Voting Rights
31st Dec 202511:23 amRNSTotal Voting Rights
19th Dec 202510:08 amRNSElections for first interim dividend
19th Dec 202510:08 amRNSElections for first interim dividend
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 202512:35 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20255:15 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.